Surgical Collaboration: Unlocking HS Treatment Potential
The 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) brought together experts to explore the evolving landscape of HS treatment. Ralph George, MD, FRCS, a renowned surgical oncologist, shared insights on the transformative impact of collaboration in HS management.
In his presentation, George highlighted the significant role of surgical interventions across the spectrum of HS. He emphasized that the growing collaboration between medical and surgical teams is revolutionizing HS treatment, allowing for more effective and comprehensive care.
The Power of Collaboration
George's key message was that surgery is becoming increasingly effective for HS, not solely due to the skills of surgeons, but because other treatments are making a substantial difference. This synergy empowers surgery to achieve even greater success. He attributed this success to the collaborative efforts of various medical professionals.
Dispelling Surgical Misconceptions
Addressing common misconceptions, George clarified that surgery is not mandatory for HS patients. He explained that surgical interventions can be highly beneficial at various stages of the disease, even for mild cases. For instance, localized, mild HS can be effectively managed with localized surgical procedures, avoiding prolonged, more invasive treatments.
Advancements in HS Research
George also discussed the rapid advancements in HS research, noting that keeping up with the latest developments is challenging. He attributed this excitement to the bench research and clinical trials that are driving surgical innovation. These advancements enable surgeons to enhance their ability to tackle HS more effectively.
The Value of Disease-Specific Meetings
George praised the unique atmosphere of the SHSA, where experts from diverse fields come together. He believes that this interdisciplinary approach enriches the learning experience for all participants, fostering collaboration and innovation.
Looking Ahead: A Brighter Future for HS
George concluded by acknowledging the long road ahead in HS treatment. He drew a parallel with breast cancer, where surgery's role is decreasing. He expressed hope that HS treatment will also evolve, potentially reducing the need for surgery. He welcomed the prospect of being rendered obsolete by advancements, indicating a positive trajectory for HS management.
